Key statistics
On Friday, Hikma Pharmaceuticals PLC (HIK:LSE) closed at 1,209.00, 0.33% above its 52-week low of 1,205.00, set on Mar 06, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1,205.00 |
|---|---|
| High | 1,234.00 |
| Low | 1,205.00 |
| Bid | 1,170.00 |
| Offer | 1,519.00 |
| Previous close | 1,210.00 |
| Average volume | 2.68m |
|---|---|
| Shares outstanding | 220.56m |
| Free float | 152.32m |
| P/E (TTM) | 7.41 |
| Market cap | 2.66bn GBP |
| EPS (TTM) | 1.62 GBP |
| Annual div (ADY) | 62.43 GBX |
|---|---|
| Annual div yield (ADY) | 5.18% |
| Div ex-date | Aug 14 2025 |
| Div pay-date | Sep 18 2025 |
| Next div ex-date | Mar 19 2026 |
| Next div pay-date | Apr 30 2026 |
Data delayed at least 20 minutes, as of Mar 06 2026 13:44 GMT.
More ▼
Investors Chronicle View
The last IC recommendation on Hikma Pharmaceuticals PLC shares was Hold at 1,750.00 on 07 Aug 2025Read the full article











